Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 17Active not recruiting 5Terminated 3Recruiting 3Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Tobacco Use Cessation 1Acquired Immunodeficiency Syndrome 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Tobacco Use Cessation Devices × Clear all
NCT02029612 2014-02-28

An Evidence Based Smoking Cessation Program for Persons Living With HIV/AIDS (Project Legacy)

M.D. Anderson Cancer Center

Phase NA Withdrawn

Acquired Immunodeficiency Syndrome, Tobacco Use Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡